首页> 外文期刊>The Journal of Neuroscience: The Official Journal of the Society for Neuroscience >Hydroxamic Acid-Based Histone Deacetylase (HDAC) Inhibitors Can Mediate Neuroprotection Independent of HDAC Inhibition (vol 34, pg 14328, 2014)

【24h】

Hydroxamic Acid-Based Histone Deacetylase (HDAC) Inhibitors Can Mediate Neuroprotection Independent of HDAC Inhibition (vol 34, pg 14328, 2014)

机译：基于异羟肟酸的组蛋白脱乙酰基酶（HDAC）抑制剂可独立于HDAC抑制而介导神经保护作用（第34卷，第14328页，2014年）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Journal of Neuroscience: The Official Journal of the Society for Neuroscience》 |2015年第1期|共1页
作者
Sleiman Sama F.; Olson David E.; Bourassa Megan W.; Karuppagounder Saravanan S.; Zhang Yan-Ling; Gale Jennifer; Wagner Florence F.; Basso Manuela; Coppola Giovanni; Pinto John T.; Holson Edward B.; Ratan Rajiv R.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Hydroxamic Acid-Based Histone Deacetylase (HDAC) Inhibitors Can Mediate Neuroprotection Independent of HDAC Inhibition (vol 34, pg 14328, 2014) [J] . Sleiman Sama F., Olson David E., Bourassa Megan W., The Journal of Neuroscience: The Official Journal of the Society for Neuroscience . 2015,第1期

机译：基于异羟肟酸的组蛋白脱乙酰基酶（HDAC）抑制剂可独立于HDAC抑制而介导神经保护作用（第34卷，第14328页，2014年）
2. Histone deacetylases inhibitor sodium butyrate inhibits JAK2/STAT signaling through upregulation of SOCS1 and SOCS3 mediated by HDAC8 inhibition in myeloproliferative neoplasms [J] . GaoS.-M., ChenC.-Q., WangL.-Y., Experimental Hematology: Official Publication of the International Society for Experimental Hematology . 2013,第3期

机译：组蛋白脱乙酰基酶抑制剂丁酸钠通过上调骨髓增生性肿瘤中HDAC8抑制介导的SOCS1和SOCS3的上调而抑制JAK2 / STAT信号传导
3. Histone Deacetylase Inhibitor Phenylbutyrate Exaggerates Heart Failure in Pressure Overloaded Mice independently of HDAC inhibition [J] . Jing Ma, Tao Luo, Zhi Zeng, Scientific reports. . 2016,第1期

机译：组蛋白脱乙酰酶抑制剂苯基丁酸盐夸大了心力衰竭的压力过载的小鼠，独立于HDAC抑制
4. THE NOVEL HDAC INHIBITOR HDAC-42 EXHIBITS BIOLOGIC ACTIVITY AGAINST MALIGNANT MAST CELL TUMORS THROUGH BOTH KIT AND HISTONE DEPENDENT PATHWAYS [C] . Tzu-Yin Lin, Sridhar Murahari, Sam Kulp, Annual Conference of the Veterinary Cancer Society . 2009

机译：新型HDAC抑制剂HDAC-42通过试剂盒和组蛋白依赖性途径对恶性肥大细胞肿瘤进行生物活性
5. The structural requirements of histone deacetylase (HDAC) inhibitors: Suberoylanilide hydroxamic acid (SAHA) analogues modified at C3, C6, and C7 positions enhance selectivity [D] . Choi, Sun Ea 2012

机译：组蛋白脱乙酰基酶（HDAC）抑制剂的结构要求：在C3，C6和C7位置修饰的Suberoylanilide异羟肟酸（SAHA）类似物可提高选择性
6. Correction: Sleiman et al. Hydroxamic Acid-Based Histone Deacetylase (HDAC) Inhibitors Can Mediate Neuroprotection Independent of HDAC Inhibition [O] . 2015

机译：更正：Sleiman等人基于异羟肟酸的组蛋白脱乙酰基酶（HDAC）抑制剂可介导独立于HDAC抑制作用的神经保护作用
7. Hydroxamic acid-based histone deacetylase (HDAC) inhibitors can mediate neuroprotection independent of HDAC inhibition [O] . Sleiman Sama F. 2014

机译：基于异羟肟酸的组蛋白脱乙酰基酶（HDAC）抑制剂可介导独立于HDAC抑制的神经保护作用
8. Inhibition of Histone Deacetylases (HDACs) and mTOR Signaling: Novel Strategies Towards the Treatment of Prostate Cancer. [R] . L. Ellis 2012

机译：抑制组蛋白去乙酰化酶（HDaCs）和mTOR信号：治疗前列腺癌的新策略。

获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

客服微信
服务号